Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Li, X; MUKANDAVIRE, C; Cucunubá, ZM; Echeverria Londono, S; ABBAS, K; Clapham, HE; JIT, M; Johnson, HL; Papadopoulos, T; VYNNYCKY, E; Brisson, M; Carter, ED; CLARK, A; De Villiers, MJ; Eilertson, K; Ferrari, MJ; Gamkrelidze, I; Gaythorpe, KA M; Grassly, NC; Hallett, TB; Hinsley, W; Jackson, ML; Jean, K; Karachaliou, A; Klepac, P; ... Vaccine Impact Modelling Consortium,
2021
The Lancet, (2021).397 10272 10.1016/S0140-6736(20)32657-X.
Durable natural killer cell responses after heterologous two-dose Ebola vaccination.
Wagstaffe, HR; Susannini, G; Thiébaut, R; Richert, L; Lévy, Y; Bockstal, V; Stoop, JN; Luhn, K; Douoguih, M; Riley, EM; Lacabaratz, C; GOODIER, MR;
2021
npj Vaccines, (2021).6 1 10.1038/s41541-021-00280-0.
Regulation of the human NK cell compartment by pathogens and vaccines.
GOODIER, MR; Riley, EM;
2021
Clinical & Translational Immunology, (2021).10 1 10.1002/cti2.1244.
Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil.
Russell, LB; Kim, S-Y; Toscano, C; Cosgriff, B; Minamisava, R; Lucia Andrade, A; SANDERSON, C; Sinha, A;
2021
VACCINE, (2021).39 1 10.1016/j.vaccine.2020.09.006.
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.
Ochalek, J; ABBAS, K; Claxton, K; JIT, M; Lomas, J;
2020
BMJ global health, (2020).5 10 10.1136/bmjgh-2020-003006.
Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
Kaboré, L; Meda, B; Médah, I; Shendale, S; Nic Lochlainn, L; SANDERSON, C; Ouattara, M; Kaboré, WM F; Betsem, E; Ogbuanu, IU;
2020
VACCINE, (2020).38 48 10.1016/j.vaccine.2020.10.021.
Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
Li, AJ; Tabu, C; Shendale, S; Sergon, K; Okoth, PO; Mugoya, IK; Machekanyanga, Z; Onuekwusi, IU; SANDERSON, C; Ogbuanu, IU;
2020
PLOS ONE, (2020).15 8 10.1371/journal.pone.0237913.
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
ABBAS, K; PROCTER, SR; VAN ZANDVOORT, K; CLARK, A; FUNK, S; Mengistu, T; Hogan, D; Dansereau, E; JIT, M; FLASCHE, S; LSHTM CMMID COVID-19 Working Group,;
2020
The Lancet Global Health, (2020).8 10 10.1016/S2214-109X(20)30308-9.
Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after ten years of pneumococcal conjugate vaccine pressure.
Usuf, E; Christian, B; Gladstone, R; Bojang, E; Jawneh, K; Cox, I; Jallow, E; Bojang, A; GREENWOOD, B; Adegbola, RA; Bentley, SD; Hill, PC; ROCA, A;
2020
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2020). 10.1093/cid/ciaa856.
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
CLARK, A; JIT, M; WARREN-GASH, C; Guthrie, B; Wang, HH X; Mercer, SW; SANDERSON, C; MCKEE, M; Troeger, C; Ong, KL; CHECCHI, F; PEREL, P; Joseph, S; GIBBS, HP; Banerjee, A; EGGO, RM; Centre for the Mathematical Modelling of Infectiou,;
2020
The Lancet. Global Health, (2020).8 8 10.1016/S2214-109X(20)30264-3.